Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Colorcon
Merck
Baxter

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VARENICLINE TARTRATE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Varenicline Tartrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00141167 A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation Completed Pfizer Phase 3 2005-02-01 The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo for smoking cessation.
NCT00141206 A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation Completed Pfizer Phase 3 2003-05-01 The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo and Zyban for smoking cessation.
NCT00143299 A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline Completed Pfizer Phase 3 2003-10-01 The primary purpose of this study is to obtain safety information on cigarette smokers treated with 52 weeks of varenicline regardless of smoking status.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Varenicline Tartrate

Condition Name

Condition Name for Varenicline Tartrate
Intervention Trials
Smoking Cessation 21
Smoking 2
Schizophrenia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Varenicline Tartrate
Intervention Trials
Schizophrenia 3
Problem Behavior 2
Mental Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Varenicline Tartrate

Trials by Country

Trials by Country for Varenicline Tartrate
Location Trials
United States 166
South Africa 20
Canada 16
Mexico 15
Brazil 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Varenicline Tartrate
Location Trials
Massachusetts 11
California 10
Pennsylvania 9
New York 8
Connecticut 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Varenicline Tartrate

Clinical Trial Phase

Clinical Trial Phase for Varenicline Tartrate
Clinical Trial Phase Trials
Phase 4 9
Phase 3 10
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Varenicline Tartrate
Clinical Trial Phase Trials
Completed 28
Not yet recruiting 2
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Varenicline Tartrate

Sponsor Name

Sponsor Name for Varenicline Tartrate
Sponsor Trials
Pfizer 25
QuitSupport 1
National Heart, Lung, and Blood Institute (NHLBI) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Varenicline Tartrate
Sponsor Trials
Industry 27
Other 10
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKesson
Mallinckrodt
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.